By using this co-pay card, you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions described below:
  • Patients are not eligible to use this card if they are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veterans Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as “La Reforma de Salud”).

  • Patient must have private insurance. Offer is not valid for cash paying patients. You will receive a maximum benefit of $10,600 per product per calendar year depending on insurance, which is defined by the date of enrollment through December 31st of the enrollment year. After a maximum is reached, you will be responsible for paying the remaining monthly out-of-pocket costs.

    • A maximum benefit for capecitabine is $500 per month and up to $6,000 annually.
  • This co-pay card is not valid when the entire cost of your prescription drug is eligible to be reimbursed by your private insurance plan or other private health or pharmacy benefit programs.
  • You must deduct the value of this co-pay card from any reimbursement request submitted to your private insurance plan, either directly by you or on your behalf.
  • You are responsible for reporting use of the co-pay card to any private insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the co-pay card, as may be required. You should not use the co-pay card if your insurer or health plan prohibits use of manufacturer co-pay cards.
  • You must be 18 years of age or older to redeem the co-pay card.

  • For AROMASIN® (exemestane), capecitabine, BOSULIF® (bosutinib), and SUTENT® (sunitinib malate), this co-pay card is not valid for Massachusetts residents whose prescriptions are covered in whole or in part by third party insurance.

  • For AROMASIN® (exemestane), capecitabine, BOSULIF® (bosutinib), and SUTENT® (sunitinib malate), this co-pay card is not valid for California residents whose prescriptions are covered in whole or in part by third party insurance.
  • This co-pay card is not valid where prohibited by law.
  • The benefit under the co-pay card program is offered to, and intended for the sole benefit of, eligible patients and may not be transferred to or utilized for the benefit of third parties, including, without limitation, third party payers, pharmacy benefit managers, or the agents of either.
  • This co-pay card cannot be combined with any other external savings, free trial or similar offer for the specified prescription (including any program offered by a third party payer or pharmacy benefit manager, or an agent of either, that adjusts patient cost-sharing obligations, through arrangements that may be referred to as “accumulator” or “maximizer” programs).
  • Third party payers, pharmacy benefit managers, or the agents of either, are prohibited from assisting patients with enrolling in the co-pay card program.
  • Co-pay card will be accepted only at participating pharmacies.
  • This co-pay card is not health insurance.
  • Offer good only in the U.S. and Puerto Rico.
  • Co-pay card is limited to 1 per product per person during this offering period and is not transferable.
  • A co-pay card may not be redeemed more than once per 30 days per patient.
  • No other purchase is necessary.
  • Data related to your redemption of the co-pay card may be collected, analyzed, and shared with Pfizer, for market research and other purposes related to assessing Pfizer’s programs. Data shared with Pfizer will be aggregated and de-identified; it will be combined with data related to other co-pay card redemptions and will not identify you.
  • Pfizer reserves the right to rescind, revoke or amend this offer without notice.
  • Offer expires 12/31/2026.
Please see Important Facts about ADCETRIS, including BOXED WARNING, or visit ADCETRIS.com.
Please see BESPONSA full Prescribing Information, including BOXED WARNING, or visit BESPONSA.com.
Please see DAURISMO Medication Guide and full Prescribing Information, including BOXED WARNING, or visit DAURISMO.com.
Please see ELREXFIO Medication Guide and full Prescribing Information, including BOXED WARNING, or visit ELREXFIO.com.
Please see MYLOTARG full Prescribing Information, including BOXED WARNING.
Please see RETACRIT Medication Guide and full Prescribing Information, including BOXED WARNING, or visit RETACRIT.com.
Please see RUXIENCE Medication Guide and full Prescribing Information, including BOXED WARNING.
Please see SUTENT Medication Guide and full Prescribing Information, including BOXED WARNING regarding serious liver problems, or visit SUTENT.com.
Please see TIVDAK Medication Guide and full Prescribing Information, including IMPORTANT WARNING, or visit TIVDAK.com.
Please see TRAZIMERA full Prescribing Information, including BOXED WARNING.